Author Index

A

  • A, Soli, I. Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
  • A., Abougabal, Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]
  • A., Ali, D. Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
  • A., Badawy, How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]
  • A., Elahmadawy, M. Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]
  • A., Nagy How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]
  • A., Tawakol, Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]
  • AK, Kyere, Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

D

  • D., Deif, Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]

F

  • F, Hasford, Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

H

  • H., Fathy, Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]
  • H., Moustafa, Role of PET/CT in Differentiated Thyroid Carcinoma. [Volume 20, Issue 1, 2020, Pages 9-17]
  • H., Moustafa, Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]
  • H., Moustafa, Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]

I

  • I., Moussa, Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

K

  • K, El-Ghamrawy, Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]

L

  • L., Zidan, Theranostics in Prostate Cancer. [Volume 20, Issue 1, 2020, Pages 1-8]

M

  • M., Elazab, Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. [Volume 20, Issue 1, 2020, Pages 39-52]
  • M., Gammal, How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]
  • M., Moustafa, How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]

N

  • N., Maamoun, Role of PET/CT in Differentiated Thyroid Carcinoma. [Volume 20, Issue 1, 2020, Pages 9-17]

O

  • O., Serry, Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]